At the Practical Cardiology Symposium on April 10, 2026, Biobeat will highlight new approaches to blood pressure monitoring designed for real world clinical practice.
In primary care, tools like ambulatory blood pressure monitoring ABPM and 24 hr blood pressure monitors remain essential for uncovering masked hypertension and improving risk assessment.
However, reliance on traditional ABPM devices can limit visibility into ongoing patient trends.
Biobeat’s FDA cleared blood pressure monitor offers a new approach through a lightweight blood pressure monitoring patch that supports continuous blood pressure monitoring.
This cuffless blood pressure monitor functions as a continuous BP monitor, enabling accurate, real time insights without interrupting daily routines.
By advancing cuffless blood pressure technology, clinicians can move toward more consistent and data driven care.
We will be sharing how our FDA cleared, medical grade, validated cuffless blood pressure monitoring platform is changing the way hypertension is diagnosed and managed, for better patients experience and better outcomes.
Be part of the discussion on how ambulatory BP monitoring is shifting toward more continuous and connected solutions.
